Navigation Links
Sinovac's CEO Weidong Yin Nominated for China Central Television's Prestigious Economic Man-of-the-Year Award
Date:12/15/2009

BEIJING, Dec. 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA), a leading provider of biopharmaceutical products in China, announced today that Weidong Yin, Chairman, President & CEO, was selected by China Central Television (CCTV) to be one of 18 nominees for China's 2009 Economic Man-of-the-Year.

CCTV's Economic Man-of-the-Year is the country's most influential and well-known business award, sometimes referred to as the "Oscar Award of the Chinese Economy." The award is granted to those business leaders who exemplify China's economic growth, are central to the Chinese economy in the current year, and represent role models of the Chinese economy.

Mr. Weidong Yin, Chairman, President and CEO of Sinovac, remarked, "For me, it's unexpected to be nominated for China's 2009 Economic Man-of-the-Year. And I am pleased to have it on my personal record. It also demonstrates that the contributions made by Sinovac, represented by me, to Chinese society has been recognized and appreciated by the public. Sinovac's management will continue to execute our business development strategy in this favorable environment and we are confident on our performance and growth. We will continue to make efforts to maximize our shareholders' interests."

The award's criteria include creativity, driving force, vision, and social responsibility. The nominees include Yu Minhong (Michael Yu), CEO of New Oriental Group and Cao Guowei (Charles Chao), CEO of Sina.com, among others. The final results will be announced on Dec. 23, 2009. Winners are chosen by a panel of expert judges, aided by votes from the public via the Internet.

Previous recipients of the Economic Man-of-the-Year award included Lin Yifu, World Bank Senior Vice President and Chief Economist; Liu Chuanzhi, Chairman of Lenovo; and Li Yanhong (Robin Li), president of Baidu.com.

About Sinovac

Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. Sinovac's vaccine products include Healive(R) (hepatitis A), Bilive(R) (combined hepatitis A and B), and Anflu(R) (influenza). Panflu(R) and PANFLU.1(TM), Sinovac's pandemic influenza vaccine (H5N1) and H1N1 vaccine, have already been approved for government stockpiling. Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccine.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

    For more information, please contact:

     Helen G. Yang
     Sinovac Biotech Ltd.
     Tel:   +86-10-8289-0088 x9871
     Fax:   +86-10-6296-6910
     Email: info@sinovac.com

     Investors:
     Amy Glynn/Stephanie Carrington
     The Ruth Group
     Tel:   +1-646-536-7023/7017
     Email: aglynn@theruthgroup.com
            scarrington@theruthgroup.com

     Media:
     Janine McCargo
     The Ruth Group
     Tel:   +1-646-536-7033
     Email: jmccargo@theruthgroup.com

SOURCE Sinovac Biotech Ltd.


'/>"/>
SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
2. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
3. BMP Sunstone Announces the Inclusion of Seventy Eight Drugs in Chinas National Insurance Catalog
4. China Biologic Products Approved to List on NASDAQ
5. China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits
6. Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA
7. China Sky One Medical, Inc. Announces Record Third Quarter 2009 Results
8. China Medicine Announces Strong Third Quarter 2009 Results
9. Chindex International Announces Participation in Brean Murray, Carret & Co. 2009 China Growth Conference
10. China National Medicines Corporation Issues Milestone Purchase Order for 12,000 STA Systems
11. China Medicine Corporation to Acquire Pharmaceutical Manufacturer in Guangzhou
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017   Icertis , the leading ... the cloud, today announced an upgrade to the ... to improve clinical trials contract management. Built on ... the solution speeds up clinical trial contracting while ... (CRO). "The pharmaceutical industry is ...
(Date:3/23/2017)... March 23, 2017 A research report ... is expected to reach USD 7.2 billion by the end ... preparation is a procedure in which a sample is preserved ... most analytical procedures since the methods are often allowing repeated ... of the most shared procedures in the lab. In many ...
(Date:3/23/2017)... , March 23, 2017 Ascendis Pharma A/S ... TransCon technology to address significant unmet medical needs in ... a conference call and webcast on Monday, April 3 ... Society in Orlando, Florida , to ... candidates (TransCon Growth Hormone, TransCon PTH and TransCon CNP). ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... March 23, 2017 , ... ... families and businesses of the Norwalk and Vermillion areas, celebrates the newest ... (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer recovery support ...
(Date:3/23/2017)... ... March 23, 2017 , ... Benefits delivery trailblazer, Hodges-Mace, ... and centralized benefits dashboard solving one of the top frustrations in employee benefits ... the first time, employees can access up-to-date information and account balances for all ...
(Date:3/23/2017)... ... March 23, 2017 , ... Hakim Unique Group ... technology company California Healthcom Group (CHG). , The HUG investment is a ... headquarters in California, CHG is a growing, internationally recognized healthcare management, technology, and ...
(Date:3/23/2017)... Scottsdale, AZ (PRWEB) , ... March 23, 2017 , ... ... helping people around the world to manage stress and anxiety. , “Buzzies change ... Serin, neuropsychologist, inventor and co-founder of Buzzies. , Since its launch date in December ...
(Date:3/23/2017)... , ... March 23, 2017 , ... ... a new solution that enables organizations to easily reprint customer invoices, bills, statements ... Server’ automates all of the steps needed to retrieve and print the documents ...
Breaking Medicine News(10 mins):